St. Louis startup developing cancer-fighting drug raises $21M

The Series B funding for Immunophotonics comes as it recently dosed the first patients in a second phase of a clinical trial in Switzerland.

Related Keywords

Switzerland ,Miguel Zubizarreta ,Lu Alleruzzo ,Jim Mckelvey ,Zubizoom Investments ,Hyland Software ,Ohio Based Hyland ,Louis Business ,